<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epilepsy Behav Case Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsy Behav Case Rep</journal-id>
<journal-title-group>
<journal-title>Epilepsy &amp; Behavior Case Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2213-3232</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30603611</article-id>
<article-id pub-id-type="pmc">6310737</article-id>
<article-id pub-id-type="publisher-id">S2213-3232(18)30133-6</article-id>
<article-id pub-id-type="doi">10.1016/j.ebcr.2018.10.004</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epilepsy phenotype in patients with Xp22.31 microduplication</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Brinciotti</surname>
<given-names>Mario</given-names>
</name>
<email>mario.brinciotti@uniroma1.it</email>
<xref ref-type="aff" rid="af0005">a</xref>
<xref ref-type="aff" rid="af0010">b</xref>
<xref ref-type="corresp" rid="cr0005">⁎</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fioriello</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="af0005">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mittica</surname>
<given-names>Antonio</given-names>
</name>
<xref ref-type="aff" rid="af0005">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernardini</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="af0015">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldoni</surname>
<given-names>Marina</given-names>
</name>
<xref ref-type="aff" rid="af0015">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matricardi</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="af0005">a</xref>
<xref ref-type="aff" rid="af0010">b</xref>
</contrib>
</contrib-group>
<aff id="af0005"><label>a</label>Department of Human Neurosciences, Sapienza University of Rome, Italy</aff>
<aff id="af0010"><label>b</label>Interdepartmental Centre for Social Diseases (CIMS), Epilepsy Section, Sapienza University of Rome, Italy</aff>
<aff id="af0015"><label>c</label>Cytogenetics Unit, Casa Sollievo della Sofferenza Foundation, San Giovanni Rotondo, Foggia, Italy</aff>
<author-notes>
<corresp id="cr0005"><label>⁎</label>Corresponding author at: Via dei Sabelli, 108, 00185 Rome, Italy. <email>mario.brinciotti@uniroma1.it</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>04</day>
<month>11</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>11</volume>
<fpage>31</fpage>
<lpage>34</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>5</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 The Authors</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="ab0005">
<p>The clinical significance of Xp22.31 microduplication is still unclear. We describe a family in which a mother and two children have Xp22.31 microduplication associated with different forms of epilepsy and epileptiform EEG abnormalities. The proband had benign epilepsy with centrotemporal spikes with dysgraphia and dyscalculia (IQ 72), the sister had juvenile myoclonic epilepsy, and both had bilateral talipes anomalies. The mother, who was the carrier of the microduplication, was asymptomatic. The asymptomatic father did not possess the microduplication. These data contribute to delineate the phenotype associated with Xp22.31 microduplication and suggest a potential pathogenic role for an epilepsy phenotype.</p>
</abstract>
<abstract abstract-type="author-highlights" id="ab0010">
<title>Highlights</title>
<p>
<list id="l0005" list-type="simple">
<list-item id="li0005">
<label>•</label>
<p id="p0005">Developmental disorders are commonly associated with Xp22.31 microduplication.</p>
</list-item>
<list-item id="li0010">
<label>•</label>
<p id="p0010">Seizures may occur but specific epileptic syndromes are rare.</p>
</list-item>
<list-item id="li0015">
<label>•</label>
<p id="p0015">Xp22.31 microduplication may have an additive role in epilepsy phenotype expression.</p>
</list-item>
</list>
</p>
</abstract>
<kwd-group id="ks0005">
<title>Abbreviations</title>
<kwd>BECTS, Benign epilepsy with centrotemporal spikes</kwd>
<kwd>SNP-array, single nucleotide polymorphism microarray</kwd>
<kwd>ILS, intermittent light stimulation</kwd>
<kwd>PS, pattern stimulation</kwd>
</kwd-group>
<kwd-group id="ks0010">
<title>Keywords</title>
<kwd>Epilepsy</kwd>
<kwd>EEG abnormalities</kwd>
<kwd>Xp22.31 microduplication</kwd>
<kwd>Phenotype</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s0005">
<label>1</label>
<title>Introduction</title>
<p id="p0020">Xp22.31 microduplication is one of the most frequent findings in clinical cytogenetic analysis <xref ref-type="bibr" rid="bb0005">[1]</xref>, <xref ref-type="bibr" rid="bb0010">[2]</xref>. The frequency varies according to the criteria of sample selection, ranging from 0.04% in multicenter studies based on noninvasive prenatal testing <xref ref-type="bibr" rid="bb0015">[3]</xref>, and 2.4% in patients with mental retardation <xref ref-type="bibr" rid="bb0020">[4]</xref>. In patients with epilepsy, Olson et al. <xref ref-type="bibr" rid="bb0025">[5]</xref> found at least one copy number variant on chromosomal microarray in 323 out of 805 studied cases (40%), and 30 of these (9.3%) had Xp22.31 microduplication. Recently, Addis et al. <xref ref-type="bibr" rid="bb0030">[6]</xref> found this duplication in 2.2% of patients with benign childhood epilepsy with centrotemporal spikes (BECTS). Even if the clinical significance of the rearrangement is still debated, the most recent studies confirm its possible pathogenic role, although probably not independently but instead linked to additional genetic factors <xref ref-type="bibr" rid="bb0035">[7]</xref>. The phenotype is variable is prevalent in neurocognitive and behavioral disorders, with seizures reported in 3–44% of cases <xref ref-type="bibr" rid="bb0010">[2]</xref>, <xref ref-type="bibr" rid="bb0025">[5]</xref>, <xref ref-type="bibr" rid="bb0030">[6]</xref>, <xref ref-type="bibr" rid="bb0035">[7]</xref>, <xref ref-type="bibr" rid="bb0040">[8]</xref>. Dysmorphic features, talipes anomalies, and feeding difficulties may also occur <xref ref-type="bibr" rid="bb0025">[5]</xref>, <xref ref-type="bibr" rid="bb0030">[6]</xref>, <xref ref-type="bibr" rid="bb0035">[7]</xref>, <xref ref-type="bibr" rid="bb0040">[8]</xref>. Severity and intensity of the phenotypes are variable; intellectual disability ranges from mild to severe mental retardation, in some patients associated with autism spectrum disorder, speech and reading difficulty, dyslexia, and attention deficit hyperactivity disorder. Also, the epilepsy phenotype varies from neonatal seizures to BECTS, Dravet-like epilepsy, and drug-resistant myoclonic epilepsy <xref ref-type="bibr" rid="bb0010">[2]</xref>, <xref ref-type="bibr" rid="bb0015">[3]</xref>, <xref ref-type="bibr" rid="bb0020">[4]</xref>, <xref ref-type="bibr" rid="bb0025">[5]</xref>, <xref ref-type="bibr" rid="bb0030">[6]</xref>, <xref ref-type="bibr" rid="bb0035">[7]</xref>, <xref ref-type="bibr" rid="bb0040">[8]</xref>. In the present study we analyzed four members of a family in which two children possess Xp22.31 microduplication associated with different forms of epilepsy.</p>
</sec>
<sec id="s0010">
<label>2</label>
<title>Material and methods</title>
<p id="p0025">We studied a nuclear family of four members (non-consanguine parents and two children). Underwritten informed consent, all members underwent clinical, EEG, neuro-imaging and laboratory evaluations based on specific clinical indications for each subject. Video-EEG monitoring was recorded in each member at rest and during standardized visual stimuli with intermittent light stimulation (ILS), pattern stimulation (PS) and watching television, according to a protocol used in our center <xref ref-type="bibr" rid="bb0045">[9]</xref>. Genomic DNA of each member was extracted from peripheral blood with standard procedures and analyzed by single nucleotide polymorphism microarray-based analysis (SNP-array Cytoscan; Affymetrix, Santa Clara, CA).</p>
</sec>
<sec id="s0015">
<label>3</label>
<title>Results</title>
<p id="p0030">The family pedigree is shown in <xref ref-type="fig" rid="f0005">Fig. 1</xref>.<fig id="f0005"><label>Fig. 1</label><caption><p>Pedigree of the family.</p></caption><alt-text id="al0005">Fig. 1</alt-text><graphic xlink:href="gr1"></graphic></fig></p>
<sec id="s0020">
<label>3.1</label>
<title>Proband</title>
<p id="p0035">Six-year-old boy (IV 27, <xref ref-type="fig" rid="f0005">Fig. 1</xref>), born at term from normal pregnancy. Normal growth in height, weight and psychomotor development. At 5.7 years of age he started to have focal seizures upon awakening with sensorimotor symptoms with tonic contraction of one side of the face, oropharyngeal automatisms, sialorrhea, and speech arrest. At school he needed educational support because of learning difficulties, dysgraphia, and dyscalculia. His full-scale intelligence quotient (WAIS-IV test) was 72 (verbal 73, performance 77). General physical examination showed bilateral talo-valgus deformities, reported by the parents to be more prominent in the first months of life. The neurological examination was normal. Waking video-EEG showed rare focal spikes and sharp waves in the centro-occipital regions without changes during ILS, PS and TV. Sleep video-EEG demonstrated bihemispheric independent centrotemporal spikes and sharp waves suggesting BECTS (<xref ref-type="fig" rid="f0010">Fig. 2</xref>A). Brain NMR was normal. Therapy was started with valproic acid and titrated to 600 mg/day with complete seizure control (last episode at the age of 7.6 years). At the end of the follow-up (age 18.11 years) he was in remission for about 10 years, with a normalized EEG recorded at the age of 13.4 years, and anti-seizure drug therapy tapered and discontinued over five years.<fig id="f0010"><label>Fig. 2</label><caption><p>A. Proband. Sleep EEG: bihemispheric independent centrotemporal spikes and sharp waves. B. Sister. Wake EEG: diffuse burst of spikes, polyspikes, generalized spike-and-wave and generalized polyspike-and-wave complexes at 3–4 Hz of high voltage. Marker amplitude in A and B = 150 μV = 100μ.</p></caption><alt-text id="al0010">Fig. 2</alt-text><graphic xlink:href="gr2"></graphic></fig></p>
</sec>
<sec id="s0025">
<label>3.2</label>
<title>Sister</title>
<p id="p0040">Thirteen-year-old girl (IV 26, <xref ref-type="fig" rid="f0005">Fig. 1</xref>) born at term from normal pregnancy. Normal growth in height, weight and psychomotor development. No learning difficulties. She came to medical attention at the age of 14 years for recurrent myoclonic jerks in the upper limbs beginning five months before. Myoclonic jerks predominantly occurred after awakening, with abrupt fall of objects, and rare drop attacks. Some episodes were triggered by visual environmental stimuli, particularly watching TV. Two months after the myoclonic onset, she had a generalized tonic–clonic seizure during wake. General physical examination showed bilateral talo-valgus. Neurological examination was normal. Her total intellectual level (WAIS-IV test) was 95 (verbal 86, performance 108). Wake video-EEG recording showed generalized epileptiform EEG abnormalities with or without concomitant myoclonic jerks at rest (<xref ref-type="fig" rid="f0010">Fig. 2</xref>B), activated by ILS (<xref ref-type="fig" rid="f0010">Fig. 2</xref>C) and PS. During watching television, she had five seizures characterized by peri-oral or head myoclonia, and an episode of abrupt rhythmic nystagmoid eye movements. The patient's clinical and EEG features were in accordance with the diagnostic criteria for juvenile myoclonic epilepsy (JME) <xref ref-type="bibr" rid="bb0050">[10]</xref>. Lamotrigine therapy was started up, but with poor seizure control, whereby it was gradually replaced with valproic acid up to 600 mg/day with complete seizure remission (normalized EEG at the age of 19.8 years) which still persisted at the end of follow-up (age of 22 years).</p>
</sec>
<sec id="s0030">
<label>3.3</label>
<title>Mother</title>
<p id="p0045">Fifty-two-year-old woman (III 28, <xref ref-type="fig" rid="f0005">Fig. 1</xref>) with unremarkable clinical history (no seizures). The general and neurological examinations were normal. The video-EEG did not show any abnormalities. Brain MRI demonstrated areas of gliosis due to previous involvement of the cerebral microcirculation.</p>
</sec>
<sec id="s0035">
<label>3.4</label>
<title>Father</title>
<p id="p0050">Sixty-three-year old man (III 27, <xref ref-type="fig" rid="f0005">Fig. 1</xref>) with unremarkable clinical history (no seizures). General and neurological examinations were normal. The video-EEG did not show any abnormalities. Brain MRI showed areas of gliosis due to previous involvement of the cerebral microcirculation.</p>
</sec>
<sec id="s0040">
<label>3.5</label>
<title>SNP-array analysis</title>
<p id="p0055">The analysis detected a microduplication of about 1.7 Mb at Xp22.31, extending from 6,449,233 to 8,135,644 bp (hg19 genomic release) in the two sons and their mother. No SNP-array alterations were found in the father.</p>
</sec>
</sec>
<sec id="s0045">
<label>4</label>
<title>Discussion</title>
<p id="p0060">In literature there are no concordant data on the pathogenicity of Xp22.31 microduplication, which has been interpreted in some cases as a variant with an unspecified meaning <xref ref-type="bibr" rid="bb0005">[1]</xref>, <xref ref-type="bibr" rid="bb0020">[4]</xref> or benign <xref ref-type="bibr" rid="bb0055">[11]</xref>, <xref ref-type="bibr" rid="bb0060">[12]</xref>, in others as a cause of developmental disorders, including autism, intellectual disability, hypotonia and eating disorders <xref ref-type="bibr" rid="bb0010">[2]</xref>, <xref ref-type="bibr" rid="bb0035">[7]</xref>, <xref ref-type="bibr" rid="bb0065">[13]</xref>. Cognitive dysfunction and learning difficulties of our proband support a potential pathogenic role of Xp22.31 microduplication. Regarding the epilepsy phenotype, previous studies reported seizures in 3–17% of cases <xref ref-type="bibr" rid="bb0010">[2]</xref>, <xref ref-type="bibr" rid="bb0025">[5]</xref>, <xref ref-type="bibr" rid="bb0035">[7]</xref> and epileptiform EEG abnormalities in 25% <xref ref-type="bibr" rid="bb0035">[7]</xref>. Recently, Esplin et al. <xref ref-type="bibr" rid="bb0040">[8]</xref> described nine patients with this type of mutation, inherited from the mother in all subjects, in which the most frequent phenotypic anomalies were cognitive disability (67%), epilepsy (44%) and talipes anomalies (33%). Epilepsy syndromes are rarely reported in patients with copy number variations at Xp22.31; among 10 cases studied by Olson et al. <xref ref-type="bibr" rid="bb0025">[5]</xref> only 3 had electro-clinical features fitting with defined epilepsy syndromes (neonatal seizures, BECTS, Dravet-like onset epilepsy). In the present study, three members had Xp22.31 microduplication, and two of them had epileptiform EEG anomalies associated with a genetic form of epilepsy, with different age-dependent syndromes (BECTS in the proband, JME in the sister). These data support the hypothesis that Xp22.31 microduplication may have a pathogenetic role in the expression of epilepsy phenotype, probably by an additive effect, as suggested by Liu et al. <xref ref-type="bibr" rid="bb0035">[7]</xref>.</p>
<p id="p0065">BECTS and JME have a complex inheritance, probably linked to the interaction of different genes similar to other common forms of genetic epilepsies <xref ref-type="bibr" rid="bb0070">[14]</xref>. In BECTS, the segregation analysis of the ‘EEG trait’ (centrotemporal spike and sharp waves) fit with a highly penetrant autosomal dominant model of inheritance, with strong evidence of a single genome-wide locus at 11p13 <xref ref-type="bibr" rid="bb0075">[15]</xref>, <xref ref-type="bibr" rid="bb0080">[16]</xref>, <xref ref-type="bibr" rid="bb0085">[17]</xref>. The segregation analysis of JME excluded a simple Mendelian modes of inheritance, while supporting a model involving two genes, one dominant and one recessive <xref ref-type="bibr" rid="bb0085">[17]</xref>, <xref ref-type="bibr" rid="bb0090">[18]</xref>. Linkage analyses, genome-wide association studies, and fine-mapping resulted in the identification of susceptibility genes ELP4 in BECTS (Pal and Greenberg, 2012). Five mendelian genes have been identified in JME (CACNB4, CASR, GABRa1, GABRD, Myoclonin1/EFHC1) <xref ref-type="bibr" rid="bb0095">[19]</xref>. Three SNP alleles (in BRD2, Cx-36, ME2) and some microdeletions (in 15q13.3, 15q11.2, and 16p13.11) also contribute risk to JME <xref ref-type="bibr" rid="bb0085">[17]</xref>, <xref ref-type="bibr" rid="bb0095">[19]</xref>. The Xp22.31 microduplication may act in close relationship with both specific epilepsy genes and cerebral maturation processes. Moreover, the phenotypic variability may be related to other modifiers in the genomic background as reduced penetrance, different genes in the region of duplication, and position effect <xref ref-type="bibr" rid="bb0040">[8]</xref>, <xref ref-type="bibr" rid="bb0100">[20]</xref>, <xref ref-type="bibr" rid="bb0105">[21]</xref>. In addition, X chromosome inactivation could also play a significant role in the expression of this duplication <xref ref-type="bibr" rid="bb0040">[8]</xref>, <xref ref-type="bibr" rid="bb0110">[22]</xref>; in fact, both children of the present family had maternal inherited Xp22.31 duplication, but their mother was asymptomatic.</p>
</sec>
<sec id="s0050">
<label>5</label>
<title>Conclusions</title>
<p id="p0070">The family we studied provides a contribution to the literature and help define a common phenotype related with Xp22.31 duplication, with special attention to the epilepsy. Our result underlines the need for further studies on mechanisms that influence its expressivity.</p>
</sec>
<sec id="s0055">
<title>Declarations of interest</title>
<p id="p0075">None.</p>
</sec>
<sec id="s0060">
<title>Consent</title>
<p id="p0080">Informed consent was obtained for all members of the family described in this manuscript.</p>
</sec>
<sec id="s0065">
<title>Funding</title>
<p id="p0085">This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p>
</sec>
<sec id="s0070">
<title>Ethical statement</title>
<p id="p0090">The work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. Informed consent was obtained for all members of the family described in this manuscript.</p>
</sec>
</body>
<back>
<ref-list id="bi0005">
<title>References</title>
<ref id="bb0005">
<label>1</label>
<element-citation id="rf0005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaffer</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>Bejjani</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kirkpatrick</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Coppinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ballif</surname>
<given-names>B.C.</given-names>
</name>
</person-group>
<article-title>The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the future</article-title>
<source/>Am J Med Genet C Semin Med Genet
          <volume>145C</volume>
<issue>4</issue>
<year>2007</year>
<fpage>335</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="pmid">17910076</pub-id>
</element-citation>
</ref>
<ref id="bb0010">
<label>2</label>
<element-citation id="rf0010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Köhler</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Sharkey</surname>
<given-names>F.H.</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Coulleaux</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Interstitial micro-duplication of Xp22.31: causative of intellectual disability or benign copy number variant?</article-title>
<source/>Eur J Med Genet
          <volume>53</volume>
<issue>2</issue>
<year>2010</year>
<fpage>93</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">20132918</pub-id>
</element-citation>
</ref>
<ref id="bb0015">
<label>3</label>
<element-citation id="rf0015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Detection of chromosome abnormalities using current noninvasive prenatal testing: a multi-center comparative study</article-title>
<source/>Biosci Trends
          <volume>12</volume>
<issue>3</issue>
<year>2018</year>
<fpage>317</fpage>
<lpage>324</lpage>
<pub-id pub-id-type="pmid">29952350</pub-id>
</element-citation>
</ref>
<ref id="bb0020">
<label>4</label>
<element-citation id="rf0020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mencarelli</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Katzaki</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Papa</surname>
<given-names>F.T.</given-names>
</name>
<name>
<surname>Sampieri</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Caselli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Uliana</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Private inherited microdeletion/microduplications: implications in clinical practice</article-title>
<source/>Eur J Med Genet
          <volume>51</volume>
<year>2008</year>
<fpage>409</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="pmid">18657637</pub-id>
</element-citation>
</ref>
<ref id="bb0025">
<label>5</label>
<element-citation id="rf0025" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Avallone</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sheidley</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Pinsky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bergin</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Copy number variation plays an important role in clinical epilepsy</article-title>
<source/>Ann Neurol
          <volume>75</volume>
<issue>6</issue>
<year>2014</year>
<fpage>943</fpage>
<lpage>958</lpage>
<pub-id pub-id-type="pmid">24811917</pub-id>
</element-citation>
</ref>
<ref id="bb0030">
<label>6</label>
<element-citation id="rf0030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Addis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sproviero</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Caraballo</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Newhouse</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Identification of new risk factors for rolandic epilepsy: CNV at Xp22.31 and alterations at cholinergic synapses</article-title>
<source/>J Med Genet
          <volume>55</volume>
<issue>9</issue>
<year>2018</year>
<fpage>607</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="pmid">29789371</pub-id>
</element-citation>
</ref>
<ref id="bb0035">
<label>7</label>
<element-citation id="rf0035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Erez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nagamani</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Wiszniewska</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications</article-title>
<source/>Hum Mol Genet
          <volume>20</volume>
<issue>10</issue>
<year>2011</year>
<fpage>1975</fpage>
<lpage>1988</lpage>
<pub-id pub-id-type="pmid">21355048</pub-id>
</element-citation>
</ref>
<ref id="bb0040">
<label>8</label>
<element-citation id="rf0040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esplin</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Slavotinek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Novelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Nine patients with Xp22.31 microduplication, cognitive deficits, seizures, and talipes anomalies</article-title>
<source/>Am J Med Genet A
          <volume>164A</volume>
<year>2014</year>
<fpage>2097</fpage>
<lpage>2103</lpage>
<pub-id pub-id-type="pmid">24800990</pub-id>
</element-citation>
</ref>
<ref id="bb0045">
<label>9</label>
<element-citation id="rf0045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brinciotti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matricardi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Paroxysmal eyelid movements in patients with visual-sensitive reflex seizures</article-title>
<source/>Epileptic Disord
          <volume>17</volume>
<issue>4</issue>
<year>2015</year>
<fpage>372</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="pmid">26586031</pub-id>
</element-citation>
</ref>
<ref id="bb0050">
<label>10</label>
<element-citation id="rf0050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasteleijn-Nolst Trenité</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Janz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Delgado-Escueta</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Consensus on diagnosis and management of JME: from founder's observations to current trends</article-title>
<source/>Epilepsy Behav
          <volume>28</volume>
<issue>Suppl. 1</issue>
<year>2013</year>
<fpage>S87</fpage>
<lpage>S90</lpage>
<pub-id pub-id-type="pmid">23756490</pub-id>
</element-citation>
</ref>
<ref id="bb0055">
<label>11</label>
<element-citation id="rf0055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaw-Smith</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Redon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rickman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Willatt</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fiegler</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Micro-array based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features</article-title>
<source/>J Med Genet
          <volume>41</volume>
<year>2004</year>
<fpage>241</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="pmid">15060094</pub-id>
</element-citation>
</ref>
<ref id="bb0060">
<label>12</label>
<element-citation id="rf0060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldwin</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Bunke</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Kogan</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray</article-title>
<source/>Genet Med
          <volume>10</volume>
<year>2008</year>
<fpage>415</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="pmid">18496225</pub-id>
</element-citation>
</ref>
<ref id="bb0065">
<label>13</label>
<element-citation id="rf0065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faletra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>D'Adamo</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Santa Rocca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carrozzi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perrone</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Pecile</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Does the 1.5 Mb microduplication in chromosome band Xp22.31 have a pathogenetic role? New contribution and a review of the literature</article-title>
<source/>Am J Med Genet A
          <volume>158A</volume>
<year>2012</year>
<fpage>461</fpage>
<lpage>464</lpage>
<pub-id pub-id-type="pmid">22140086</pub-id>
</element-citation>
</ref>
<ref id="bb0070">
<label>14</label>
<element-citation id="rf0070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keddache</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Tomasini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shinnar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Resor</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Genome scan of idiopathic generalized epilepsy: evidence for major susceptibility gene and modifying genes influencing the seizure type</article-title>
<source/>Ann Neurol
          <volume>49</volume>
<issue>3</issue>
<year>2001</year>
<fpage>328</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="pmid">11261507</pub-id>
</element-citation>
</ref>
<ref id="bb0075">
<label>15</label>
<element-citation id="rf0075" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strug</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baskurt</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator protein complex 4 (ELP4)</article-title>
<source/>Eur J Hum Genet
          <volume>17</volume>
<issue>9</issue>
<year>2009</year>
<fpage>1171</fpage>
<lpage>1181</lpage>
<pub-id pub-id-type="pmid">19172991</pub-id>
</element-citation>
</ref>
<ref id="bb0080">
<label>16</label>
<element-citation id="rf0080" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Strug</surname>
<given-names>L.J.</given-names>
</name>
</person-group>
<article-title>Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves</article-title>
<source/>Genes Brain Behav
          <volume>9</volume>
<issue>8</issue>
<year>2010</year>
<fpage>1004</fpage>
<lpage>1012</lpage>
<pub-id pub-id-type="pmid">20825490</pub-id>
</element-citation>
</ref>
<ref id="bb0085">
<label>17</label>
<element-citation id="rf0085" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<chapter-title>Major susceptibility genes for common idiopathic epilepsies: ELP4 in Rolandic epilepsy and BRD2 in juvenile myoclonic epilepsy</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Noebels</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Avoli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rogawski</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Delgado-Escueta</surname>
<given-names>A.V.</given-names>
</name>
</person-group>
<source/>Jasper's basic mechanisms of the epilepsies
          <edition>4th ed.</edition>
<year>2012</year>
<publisher-name>National Center for Biotechnology Information (US)</publisher-name>
<publisher-loc>Bethesda (MD)</publisher-loc>
<fpage>1</fpage>
<lpage>15</lpage>
</element-citation>
</ref>
<ref id="bb0090">
<label>18</label>
<element-citation id="rf0090" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenberg</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Delgado-Escueta</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Maldonado</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Widelitz</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Segregation analysis of juvenile myoclonic epilepsy</article-title>
<source/>Genet Epidemiol
          <volume>5</volume>
<year>1988</year>
<fpage>81</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">3136050</pub-id>
</element-citation>
</ref>
<ref id="bb0095">
<label>19</label>
<element-citation id="rf0095" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado-Escueta</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Koeleman</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Durón</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>The quest for juvenile myoclonic epilepsy genes</article-title>
<source/>Epilepsy Behav
          <volume>28</volume>
<issue>Suppl. 1</issue>
<year>2013</year>
<fpage>S52</fpage>
<lpage>S57</lpage>
<pub-id pub-id-type="pmid">23756480</pub-id>
</element-citation>
</ref>
<ref id="bb0100">
<label>20</label>
<element-citation id="rf0100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinjan</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>van Heyningen</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Position effect in human genetic disease</article-title>
<source/>Hum Mol Genet
          <volume>7</volume>
<issue>10</issue>
<year>1998</year>
<fpage>1611</fpage>
<lpage>1618</lpage>
<pub-id pub-id-type="pmid">9735382</pub-id>
</element-citation>
</ref>
<ref id="bb0105">
<label>21</label>
<element-citation id="rf0105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarado</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Aferol</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>McCall</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Techy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Buchan</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Familial isolated clubfoot is associated with recurrent chromosome 17q23.1q23.2 microduplications containing TBX4</article-title>
<source/>Am J Hum Genet
          <volume>87</volume>
<year>2010</year>
<fpage>154</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="pmid">20598276</pub-id>
</element-citation>
</ref>
<ref id="bb0110">
<label>22</label>
<element-citation id="rf0110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carrel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Willard</surname>
<given-names>H.F.</given-names>
</name>
</person-group>
<article-title>X-inactivation profile reveals extensive variability in X-linked gene expression in females</article-title>
<source/>Nature
          <volume>434</volume>
<year>2005</year>
<fpage>400</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="pmid">15772666</pub-id>
</element-citation>
</ref>
</ref-list>
<ack id="ac0005">
<title>Acknowledgments</title>
<p>We thank all members of this family for their participation and collaboration.</p>
</ack>
</back>
</article>
</pmc-articleset>